Skip to main content
    S

    SAB Biotherapeutics Inc (SABSW)

    Official site

    BIOTECHNOLOGY • NASDAQ

    $0.01
    +0.00 (+0.00%)

    Last updated: Oct 13, 2026 at 5:00 PM ET

    Earnings

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    Period ending Sep 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-N/A---
    Jun 26EST
    		-N/A---
    Jun 21
    Reported Sep 30
    		$-0.12$0.00N/AMiss-172.4%
    Mar 21
    Reported Jun 30
    		$-0.02$0.00N/AMiss-243.7%
    Dec 20
    Reported Mar 31
    		$-0.02$0.00N/AMiss-243.7%
    Sep 20
    Reported Dec 31
    		$0.16$0.00N/ABeat-
    Jun 20
    Reported Sep 30
    		$0.17$0.00N/ABeat-
    Mar 20
    Reported Jun 30
    		$0.02$0.00N/ABeat-
    Dec 19
    Reported Mar 31
    		$0.02$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.01xFCF Yield-8680.95%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-11.30%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage56.15x
    Current Ratio9.22xQuick Ratio9.22x
    Trading Statistics
    Beta0.58Avg Volume39.29K
    52-Week High$0.0952-Week Low$0.00

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.01
    SMA 20$0.01
    SMA 50$0.02
    SMA 200$0.02
    EMA 10$0.01
    EMA 20$0.01
    EMA 50$0.02
    EMA 200$0.02

    MACD

    Line: -0.00Signal: -0.00Hist: -0.00

    ADX

    ADX: 70.3+DI: 65.1-DI: 12.0

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down88.0
    PSAR$0.04

    Bollinger Bands

    Upper Band$0.02
    Lower Band$0.01
    %B Position5825%(Upper)
    Band Width0.14

    RSI (14-Day)

    Neutral
    37.3

    Momentum Oscillators

    Stoch %K18.9
    Stoch %D16.5
    Williams %R-79.8
    ROC (10d)-25.0%
    Momentum-0.00
    CCI (20d)-142.7
    MFI (14d)60.6

    Volatility Measures

    ATR (14d)$0.01(52.8%)
    StdDev (20d)0.00
    Hist Vol139.1%(High)

    Volume Flow

    VWAP$0.01
    OBV3.2M
    AD Line-4.4M
    CMF (20d)-0.260

    Volume Metrics

    Avg Vol (20d)37.5K
    Vol RatioN/A
    VWMA (20d)$0.01

    Pivot Points

    R3$0.02
    R2$0.02
    R1$0.01
    Pivot Point$0.01
    S1$0.01
    S2$0.01
    S3$0.00

    Advanced Oscillators

    TSI-23.05
    Ultimate Osc20.4
    KST-342.72

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$114,698$-410$263,137$944,575$305,011$1.27M
    Cost of RevenueN/A$752,670$763,299$765,469$822,000$7.66M$785,713$966,860$1.02M$1.98M$944,401$985,446
    Gross ProfitN/A$-752,670$-763,299$-765,469$-822,000$-7,657,321$-671,015$-966,860$-758,863$-1,040,171$-639,000$281,915
    Operating Expenses$23.38M$19.25M$15.01M$11.91M$8.91M$3.11M$9.34M$10.34M$9.44M$10.35M$18.23M$5.60M
    R&D$16.17M$13.38M$10.73M$8.95M$7.00M$7.66M$7.63M$7.83M$6.80M$8.12M$4.30M$4.02M
    SG&A$7.21M$6.60M$5.04M$3.71M$2.74M$3.11M$2.67M$3.48M$3.64M$4.19M$14.88M$2.57M
    Operating Income$-23,377,000$-19,997,736$-15,770,231$-12,678,969$-9,732,061$-10,772,102$-10,008,840$-11,309,366$-10,201,698$-11,390,616$-18,874,000$-5,323,000
    Interest Income$1.71M$1.05M$700,739$655,233$13,562$62,498$136,374$277,174$374,557$497,893$484,046$14,364
    Interest Expense$62,000$62,744$63,462$43,292$64,345$69,565$70,876$78,036$93,119$76,371$77,879$69,700
    Income Before Tax$-22,491,000$-18,868,885$-16,860,743$45.45M$-10,114,270$-5,196,773$-11,394,699$-10,349,410$-7,335,455$-5,025,745$-22,857,000$-5,102,000
    Income Tax Expense$0$0$0$0$0$0$13.38M$0$0$-13,375,000$-1$166,883
    Net Income$-22,491,000$-18,868,885$-16,860,743$45.45M$-10,114,270$-5,196,773$-11,394,699$-10,349,410$-7,335,455$-5,025,745$-22,857,000$-5,102,000
    EBITDA$-21,594,670$-18,053,471$-16,033,982$46.25M$-9,227,925$-4,348,907$-10,538,107$-9,304,511$-6,220,338$-2,964,627$-21,834,000$-4,047,000
    EBIT$-22,429,000$-18,806,141$-16,797,281$45.49M$-10,049,925$-5,127,208$-11,323,820$-10,271,371$-7,242,338$-4,949,373$-22,778,401$-5,032,446
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SABSW

    News

    No news available

    Company news will appear here when available

    SABSW Valuation and Fair Value

    P/FCF
    -0.0x
    P/B
    0.0x
    See GNG's fair value

    SABSW Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -11.3%
    FCF margin
    -63378.3%
    FCF yield
    -8680.9%

    SABSW Competitors

    CompanyTicker
    GlucoTrack IncGCTK
    Profusa, Inc. Common StockPFSA
    Bone Biologics CorpBBLG
    Venus Concept IncVERO
    Scinai Immunotherapeutics LtdSCNI
    CERo Therapeutics Holdings, Inc. Common StockCERO
    VSee Health, Inc.VSEE
    Tivic Health Systems IncTIVC

    Sector: Healthcare

    SABSW Bull Case vs Bear Case

    Bear case

    • SABSW's quarterly revenue changed -62.4% year over year.

    SABSW Earnings: Beat Rate and Next Report

    Beat rate
    4 of 7 quarters (57.1%)

    Frequently Asked Questions About SABSW

    Does SABSW pay dividends?

    SAB Biotherapeutics Inc (SABSW) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In